Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration (Q36609957)

15 August 2017

title

Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration (English)

1 reference

15 August 2017

1 reference

Raymond Tak Fai Cheung

1

1 reference

15 August 2017

George L Tipoe

2

1 reference

15 August 2017

Sidney Tam

3

1 reference

15 August 2017

Edmond Shiu Kwan Ma

4

1 reference

15 August 2017

Liang Yu Zou

5

1 reference

15 August 2017

Pui Shan Chan

6

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Journal of Pineal Research

15 August 2017

published in

1 reference

15 August 2017

volume

41

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

337-343

1 reference

Tissue plasminogen activator for acute ischemic stroke

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

NXY-059 for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin mitigates mitochondrial malfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Current status and perspectives of neuroprotection in ischemic stroke treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

New toxicity data for the propylene glycol ethers - a commitment to public health and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Existence of melatonin in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

10.1111/J.1600-079X.2006.00372.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference